Four years after selling his namesake bank a major player in Boston’s biotech scene to SVB, Jeff Leerink has pulled it out of the rubble of the tech lender’s crash.
Massachusetts was one of the first states to invest in the biotechnology industry, and government officials continue to see this sector as an important part of the state's economy